Using data from more than five thousand people, scientists have identified the gene responsible for identifying the gene that triggers the division of malignant blood cells. Drugs targeting the TCL1A gene are likely to be able to suppress the growth of cancer cells, writes "Газета.ru".
The authors noted that dividing cells in the body acquire mutations with age. Most of these mutations are harmless, but more than 10% of older people develop mutations in blood stem cells that can lead to the development of blood cancer and cardiovascular diseases.
It also turned out that some people have a mutation in this gene that prevents the inclusion of TCL1A, which protects them from blood cancer.
